MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$130,925K
Marketable securities -
available-for-sale debt securities
$98,509K
Prepaid expenses and
other current assets
$77,012K
Inventories, net
$33,233K
Accounts receivable
$27,663K
Restricted cash
$1,493K
Total current assets
$368,835K
Operating lease
right-of-use assets, net
$72,563K
Property and equipment,
net
$61,908K
Intangible assets, net
$18,976K
Deferred tax asset
$3,575K
Long-term deposits
$1,014K
Prepaid expenses and
other non-current...
$194K
Total assets
$527,065K
Total liabilities and
shareholders equity
$527,065K
Total liabilities
$418,239K
Total shareholders
equity
$108,826K
Accumulated deficit
-$1,458,350K
Accumulated other
comprehensive loss
-$6,627K
Liabilities related to
future royalties and...
$277,268K
Operating lease
liabilities, non-current
$76,895K
Total current
liabilities
$63,599K
Other long-term
payables
$477K
Additional paid-in capital
$1,573,673K
Ordinary and deferred
shares, value-Deferred...
$118K
Ordinary and deferred
shares, value-Ordinary...
$12K
Accrued expenses and
other liabilities
$46,766K
Liabilities related to
future royalties and...
$11,900K
Operating lease
liabilities, current
$3,061K
Accounts payable
$1,872K
Compensation and benefits
$18,718K
Manufacturing accruals
$7,544K
Rebates, chargebacks and
returns
$6,730K
Professional fees
$5,655K
Research and development
costs
$5,506K
Other liabilities
$2,613K
Back
Back
Balance Sheet
source: myfinsight.com
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)